Philips on Monday said it will pay $1.1 billion to settle claims in the United States over allegations tied to faulty breathing machines.
Millions of Philips sleep apnea devices were recalled in 2021 over concerns that they carried a potential cancer risk, and the company has agreed to halt U.S. sales. The settlement includes a $1.075 billion personal injury settlement and $25 million for medical monitoring.
